Second IVIg course in Guillain‐Barré syndrome patients with poor prognosis (SID‐GBS trial): Protocol for a double‐blind randomized, placebo‐controlled clinical trial.

Saved in:
Bibliographic Details
Title: Second IVIg course in Guillain‐Barré syndrome patients with poor prognosis (SID‐GBS trial): Protocol for a double‐blind randomized, placebo‐controlled clinical trial.
Authors: Walgaard, Christa1, Jacobs, Bart C.1,2, Lingsma, Hester F.3, Steyerberg, Ewout W.3,4, Cornblath, David R.5, van Doorn, Pieter A.1 p.a.vandoorn@erasmusmc.nl, van Doorn, P.A.6, Jacobs, B.C.6,7, Walgaard, C.6, de Wit, M.C.Y.6, Steyerberg, E.W.4,8,9, Cornblath, D.R.10, van den Berg, B.6,11, Doets, A.Y.6, Leonhard, S.E.6, Verboon, J.C.6, van Woerkom, M.6, Tio‐Gillen, A.P.7, van Rijs, W.7, Huizinga, H.7
Source: Journal of the Peripheral Nervous System. Dec2018, Vol. 23 Issue 4, p210-215. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first